INSMED INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 1,369,050 | Withheld: Source values require review | Withheld: Dollar values are not verified, so portfolio weights are withheld | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2025 |
| June 30, 2025 | 2,253,435 | Withheld: Source values require review | Withheld: Dollar values are not verified, so portfolio weights are withheld | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 15, 2025 |
| Sept. 30, 2025 | 2,423,435 | Withheld: Source values require review | Withheld: Dollar values are not verified, so portfolio weights are withheld | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 14, 2025 |
| Dec. 31, 2025 | 1,481,752 | Withheld: Source values require review | Withheld: Dollar values are not verified, so portfolio weights are withheld | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 17, 2026 |
| March 31, 2026 | 1,154,090 | Withheld: Source values require review | Withheld: Dollar values are not verified, so portfolio weights are withheld | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2026 |
| June 30, 2026 | 1,424,690 | Withheld: Source values require review | Withheld: Dollar values are not verified, so portfolio weights are withheld | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.